VOOZH about

URL: https://www.nature.com/articles/d41586-021-03025-0?error=cookies_not_supported&code=58df8bf8-694b-4526-b754-32780785493f

⇱ How protein-based COVID vaccines could change the pandemic


Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Pamela Sherry is eager to become immunized against COVID-19. But she has put off getting a jab.

Access options

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

$32.99 / 30 days

cancel any time

Subscribe to this journal

Receive 52 print issues and online access

$199.00 per year

only $3.83 per issue

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Nature 599, 359-360 (2021)

doi: https://doi.org/10.1038/d41586-021-03025-0

Updates & Corrections

  • Clarification 11 November 2021: This story was updated to acknowledge protein-based COVID-19 vaccines already in circulation in countries such as Cuba and Taiwan.

References

  1. Dunkle, L. M. et al. Preprint at medRxiv https://doi.org/10.1101/2021.10.05.21264567 (2021).

  2. Keech, C. et al. N. Engl. J. Med. 383, 2320-2332 (2020).

    Article  PubMed  Google Scholar 

  3. Richmond, P. et al. Lancet https://doi.org/10.1016/S0140-6736(21)00241-5 (2021).

    Article  Google Scholar 

  4. Hsieh, S.-M. et al. Lancet Resp. Med. https://doi.org/10.1016/S2213-2600(21)00402-1 (2021).

    Article  Google Scholar 

Download references

  • 👁 Image
    COVID vaccine boosters: the most important questions

  • 👁 Image
    Mix-and-match COVID vaccines ace the effectiveness test

  • 👁 Image
    The tangled history of mRNA vaccines

  • 👁 Image
    The fight to manufacture COVID vaccines in lower-income countries

  • 👁 Image
    Why is it so hard to investigate the rare side effects of COVID vaccines?

Subjects

Latest on:

  • 👁 Image

    TB vaccine from the 1920s shows promise in diabetes trial

    News

  • 👁 Image

    Better diagnostics could have limited this Ebola outbreak

    World View

  • 👁 Image

    Ebola can be stopped — but only if world leaders prioritize public health

    Editorial

  • 👁 Image

    Exclusive: NIH ousts infectious-disease leaders as COVID scientists face US charges

    News

  • 👁 Image

    At last, a pill that can prevent COVID after exposure to infected people

    News

  • 👁 Image

    Steric hindrance of antibody binding in an Omicron spike fusion intermediate

    Article

Jobs

👁 Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links